1. 1. Fewtrell MS, Loh KL, Blake A, Ridout DA, Hawdon J. Randomised, double blind trial of oxytocin nasal spray in mothers expressing breast milk for preterm infants. Arch Dis Child Fetal Neonatal Ed 2006;91:F169-74. [DOI:10.1136/adc.2005.081265]

2. Ruis H, Rolland R, Doesburg W, Broeders G, Corbey R. Oxytocin enhances onset of lactation among mothers delivering prematurely. Send to Br Med J 1981;283:340-2. [DOI:10.1136/bmj.283.6287.340]

3. Ochekpe N, Olorunfemi P, Ngwuluka N. Nanotechnology and drug delivery, Part 2: Nanostructures for drug delivery. Trop J Pharm Res 2009: 8: 275-287. [DOI:10.4314/tjpr.v8i3.44547]

4. Madan JR, Khude PA, Dua k. Development and evalution of solid lipid nano particles of mometasone furoare for topical delivery. Int J Pharm Investig 2014; 4: 60-4. [DOI:10.4103/2230-973X.133047]

5. Patidar A, Thakur DS, Kumar P, Verma J. A review on novel lipid based nanocarriers. Int J Pharm Sci 2010; 2: 30-35.

6. Attama AA, Momoh MA, Builders PF. Lipid nanoparticulate drug delivery systems: a revolution in dosage form design and development. In: Sezar AD, Editor. Pharmacology, toxicology and pharmaceutical science. Croatia: InTech open Access Publisher; 2012.

7. Elnaggar YS, El-Massik MA, Abdallah OY. Fabrication, appraisal, and transdermal permeation of sildenafil citrate-loaded nanostructured lipid carriers versus solid lipid nanoparticles. Int J Nanomedicine 2011;6:3195-205. [DOI:10.2147/IJN.S25825]

8. Kaur J, Singh G, Saini S, Rana A. Innivation growth in developing new methods for formulation solid lipid nanoparticles and microparticles. J Drug Deliv Therap 2012; 2:55-59. [DOI:10.22270/jddt.v2i5.295]

9. Waghmare A, Grampurohit N, Gadhave M, Gaikwad D, Jadhav S. Solid lipid nanoparticles: a promising drug delivery system. Int Res J Pharm 2012; 3: 100-107.

10. Malenka RC, Nestler EJ, Hyman SE. Neuropeptides. In: Sydor A, Brown RY, Editors. Molecular neuropharmacology: a foundation for clinical neuroscience. 2nd ed. New York: McGraw-Hill Medical; 2009.

11. Müller RH, Mäder K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art. Eur J Pharm Biopharm 2000;50:161-77. [DOI:10.1016/S0939-6411(00)00087-4]

12. Varshosaz J, Ghaffari S, Khoshayand MR, Atyabi F, Azarmi S, Kobarfard F. Development and optimization of solid lipid nanoparticles of amikacin by central composite design. J Liposome Res 2010;20:97-104. [DOI:10.3109/08982100903103904]

13. Ghaffari S, Varshosaz J, Saadat A, Atyabi F. Stability and antimicrobial effect of amikacin-loaded solid lipid nanoparticles. Int J Nanomed 2011;6:35-43. [DOI:10.2147/IJN.S13671]